Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-r...

Full description

Bibliographic Details
Main Authors: O'Day, Elizabeth (Author), Hosta-Rigau, Leticia (Author), Oyarzún, Diego A. (Author), Okano, Hideyuki (Author), de Lorenzo, Víctor (Author), von Kameke, Conrad (Author), Alsafar, Habiba (Author), Cao, Cong (Author), Chen, Guo-Qiang (Author), Ji, Weizhi (Author), Roberts, Richard J. (Author), Ronaghi, Mostafa (Author), Yeung, Karen (Author), Zhang, Feng (Author), Lee, Sang Yup (Author)
Other Authors: McGovern Institute for Brain Research at MIT (Contributor), Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor)
Format: Article
Language:English
Published: Wiley, 2020-08-07T18:48:59Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items